These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27638852)

  • 1. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.
    Wang Y; Peng W; Zhang X; Qiao H; Wang L; Xu Z; Wu C
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy.
    Jacobsen P; Rossing K; Rossing P; Tarnow L; Mallet C; Poirier O; Cambien F; Parving HH
    Kidney Int; 1998 Apr; 53(4):1002-6. PubMed ID: 9551410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus.
    Yoshida H; Kuriyama S; Atsumi Y; Tomonari H; Mitarai T; Hamaguchi A; Kubo H; Kawaguchi Y; Kon V; Matsuoka K; Ichikawa I; Sakai O
    Kidney Int; 1996 Aug; 50(2):657-64. PubMed ID: 8840299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of angiotensin converting enzyme insertion/deletion gene polymorphism on diabetic kidney disease: A debatable issue.
    Zeng WL; Yang SK; Song N; Chu FF
    Nefrologia (Engl Ed); 2022; 42(4):415-431. PubMed ID: 36460431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM followed Up for 9 years.
    Huang XH; Rantalaiho V; Wirta O; Pasternack A; Hiltunen TP; Koivula T; Malminiemi K; Nikkari T; Lehtimäki T
    Nephron; 1998 Sep; 80(1):17-24. PubMed ID: 9730698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease in lebanese patients with diabetic nephropathy.
    Fawwaz S; Balbaa M; Fakhoury H; Borjac J; Fakhoury R
    Saudi J Kidney Dis Transpl; 2017; 28(2):325-329. PubMed ID: 28352015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiotensin converting enzyme (ACE) gene polymorphism in a diabetic cohort and diabetic nephropathy].
    Levinson O; Oren S; Yagil C; Sapojnikov M; Wechsler A; Bloch R; Yagil Y
    Harefuah; 1999 May; 136(10):768-73, 843. PubMed ID: 10955109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?
    Andersen S; Tarnow L; Cambien F; Rossing P; Juhl TR; Deinum J; Parving HH
    Kidney Int; 2002 Jul; 62(1):192-8. PubMed ID: 12081578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.
    Park HC; Choi SR; Kim BS; Lee TH; Kang BS; Choi KH; Lee HY; Han DS; Ha SK
    Yonsei Med J; 2005 Dec; 46(6):779-87. PubMed ID: 16385653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme (ACE) gene II genotype protects against the development of diabetic peripheral neuropathy in type 2 diabetes mellitus.
    Mansoor Q; Javaid A; Bilal N; Ismail M
    J Diabetes; 2012 Sep; 4(3):257-61. PubMed ID: 22607040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.
    Rahimi Z; Felehgari V; Rahimi M; Mozafari H; Yari K; Vaisi-Raygani A; Rezaei M; Malek-Khosravi S; Khazaie H
    Mol Biol Rep; 2011 Mar; 38(3):2117-23. PubMed ID: 20853144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE.
    Uhm WS; Lee HS; Chung YH; Kim TH; Bae SC; Joo KB; Kim TY; Yoo DH
    Lupus; 2002; 11(4):227-33. PubMed ID: 12043886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients.
    Degirmenci I; Kebapci N; Basaran A; Efe B; Gunes HV; Akalin A; Kurt H; Urhan M; Demirustu C
    Int J Clin Pract; 2005 Oct; 59(10):1137-42. PubMed ID: 16178979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.
    Lee YJ; Jang HR; Kim SG; Chae DW; Do JY; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Nephrology (Carlton); 2011 Jul; 16(5):502-10. PubMed ID: 21303424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DD genotype of the ACE gene polymorphism is associated with diabetic nephropathy in the type-1 diabetics.
    Azar ST; Zalloua PA; Medlej R; Halabi G
    Endocr Res; 2001; 27(1-2):99-108. PubMed ID: 11428725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I; Mtiraoui N; Kacem M; Chaieb M; Mahjoub T; Almawi WY
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
    DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.